Live from the NIH registry
Studies recruiting near Oxnard right now
Top 25 of 130 recruiting studies, sorted by proximity — each links to its official registry page
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Community Memorial Health System — Ventura, California (8.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Clinical Trials Research Institute — Thousand Oaks, California (19.7 mi)
· Sponsor: Incyte Corporation
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Community Memorial Hospital — Ventura, California (8.5 mi)
· Sponsor: Penumbra Inc.
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Psoriatic Arthritis
Phase 3
Interventional 1,182 participants sought
The Cohen Medical Centers — Thousand Oaks, California (19.7 mi)
· Sponsor: Takeda
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Vitiligo, Non-Segmental Vitiligo (NSV)
Phase 2
Interventional 66 participants sought
Cura Clinical Research - Oxnard — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Ventura, California (8.5 mi)
· Sponsor: Medtronic
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
Los Robles Regional Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Medtronic Cardiovascular
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Ventura County Hematology Oncology Specialists — Oxnard, California (0.3 mi)
· Sponsor: BeOne Medicines
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Obesity, Overweight
Phase 3
Interventional 125 participants sought
Carey Chronis MD Pediatric, Infant and Adolescent Medicine — Oxnard, California (0.3 mi)
· Sponsor: Eli Lilly and Company
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400025 — Thousand Oaks, California (19.7 mi)
· Sponsor: Sanofi
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,000 participants sought
Research Site — Thousand Oaks, California (19.7 mi)
· Sponsor: AstraZeneca
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
Periodontal Diseases, Periodontitis
N/A
Interventional 70 participants sought
805 Dentistry — Thousand Oaks, California (19.7 mi)
· Sponsor: Erchonia Corporation
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1029 — Thousand Oaks, California (19.7 mi)
· Sponsor: Immunovant Sciences GmbH
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Cura Clinical Research - Oxnard- Site Number : 8400062 — Oxnard, California (0.3 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
HER2-negative Breast Cancer Patients With Brain Metastases
Phase 2
Interventional 120 participants sought
FOMAT Medical Research (Network) — Oxnard, California (0.3 mi)
· Sponsor: Biostar Pharma, Inc.
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2, Phase 3
Interventional 274 participants sought
California Retina Consultants — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 36 — Oxnard, California (0.3 mi)
· Sponsor: BioStem Technologies
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Thousand Oaks, California (19.7 mi)
· Sponsor: MoonLake Immunotherapeutics AG
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Diabetic Kidney Disease (DKD)
Phase 2
Interventional 195 participants sought
FOMAT - Vista del Mar Medical Group — Oxnard, California (0.3 mi)
· Sponsor: Regeneron Pharmaceuticals
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile, Clostridium Difficile Infections
Phase 3
Interventional 852 participants sought
Clinical Trials Management Services — Thousand Oaks, California (19.7 mi)
· Sponsor: Vedanta Biosciences, Inc.
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
Phase 3
Interventional 200 participants sought
Clinical Trials Research Institute /ID# 263846 — Thousand Oaks, California (19.7 mi)
· Sponsor: AbbVie
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 2 — Oxnard, California (0.3 mi)
· Sponsor: Janssen Research & Development, LLC
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Phase 3
Interventional 975 participants sought
California Retina Consultants — Oxnard, California (0.3 mi)
· Sponsor: Regeneron Pharmaceuticals
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
N/A
Interventional 1,616 participants sought
Los Robles Hospital & Medical Center — Thousand Oaks, California (19.7 mi)
· Sponsor: Boston Scientific Corporation
A Study to Explore the Role of Gut Flora in COVID-19 Infection
Gut Microbiome, Gastrointestinal Microbiome
N/A
Observational 250 participants sought
ProgenaBiome — Ventura, California (8.5 mi)
· Sponsor: ProgenaBiome